Arcadia Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Arcadia Biosciences generated cash of -$15,294,000, which is less than the previous year. Cash used in financing activities reached the amount of $5,512,000 last year. Net change in cash is therefore -$14,126,000.
Cash Flow
| 2014 | -14.78M | -1.59M | 30.11M |
|---|---|---|---|
| 2015 | -15.10M | -46.36M | 68.87M |
| 2016 | -17.05M | -5.30M | 396K |
| 2017 | -13.96M | 47.17M | -26.10M |
| 2018 | -13.63M | -5.97M | 22.47M |
| 2019 | -17.19M | -8.36M | 21.98M |
| 2020 | -30.21M | 17.28M | 20.56M |
| 2021 | -25.86M | 16.60M | 21.9M |
| 2022 | -13.97M | 1.41M | 4.51M |
| 2023 | -15.29M | -4.34M | 5.51M |
RKDA Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 20.64M | 28.68M | 16.04M | 8.41M | 11.99M | 9.12M | 2.01M | 23.97M | 16.57M | 2.83M |
Operating activities | ||||||||||
Net income | -13.98M | -15.61M | -16.13M | -6.02M | -28.87M | -13.48M | -15.70M | -19.62M | -17.95M | -18.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 984K | 479K | 1.04M | 662K | 194K | 154K | 279K | 304K | 294K | 358K |
Stock-based compensation expense | 717K | 1.10M | 1.54M | 2.04M | 2.28M | 0 | 1.47M | 1.05M | 1.39M | 976K |
| Deferred income tax benefit | 717K | 1.10M | 1.54M | 2.04M | 2.28M | 0 | 1.47M | 1.05M | 1.39M | 976K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 184K | 592K | -40K | -1.11M | -437K | 1.06M | -882K | 357K | 336K | -393K |
Inventories | 444K | 1.11M | -2.38M | -9.75M | -1.53M | 160K | 183K | 582K | 412K | 412K |
Accounts payable | -522K | -757K | -372K | -580K | 2.10M | 176K | 87K | -19K | 125K | -388K |
Cash generated by operating activities | -15.29M | -13.97M | -25.86M | -30.21M | -17.19M | -13.63M | -13.96M | -17.05M | -15.10M | -14.78M |
Investing activities | ||||||||||
Purchases Of Investments | -7.52M | -569K | 25.14M | -1.29M | -28.35M | -29.88M | -19.40M | -41.38M | -48.71M | -1.45M |
Investments In Property Plant And Equipment | -5K | -72K | -1.00M | -2.33M | -1.47M | -250K | -79K | -231K | -151K | -148K |
Acquisitions Net | 569K | 569K | -4.25M | 2.65M | 705K | 10K | 4K | 0 | 10K | 0 |
Cash generated by investing activities | -4.34M | 1.41M | 16.60M | 17.28M | -8.36M | -5.97M | 47.17M | -5.30M | -46.36M | -1.59M |
Financing activities | ||||||||||
Common Stock Issued | 5.99M | 5M | 23.29M | 8M | 7.5M | 0 | 24K | 442K | 68.22M | 19K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -197K | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -2.14M | -34K | -8K | 0 | -25M | -46K | 10.20M | -1.15M |
Cash used in financing activities | 5.51M | 4.51M | 21.9M | 20.56M | 21.98M | 22.47M | -26.10M | 396K | 68.87M | 30.11M |
Net Change In Cash | -14.12M | -8.04M | 12.64M | 7.62M | -3.58M | 2.87M | 7.11M | -21.96M | 7.40M | 13.73M |
Cash at end of period | 6.51M | 20.64M | 28.68M | 16.04M | 8.41M | 11.99M | 9.12M | 2.01M | 23.97M | 16.57M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |